Clinical Researches

Juvenile dermatomyositis (JDM), a challenging and uncommon autoimmune disorder, requires precise treatment strategies to improve patient outcomes. The treat-to-target (T2T) approach, emphasizing clear therapeutic...

Takeda has released promising interim data from its Phase 1b clinical study, showcasing the sustained efficacy of mezagitamab in primary IgA nephropathy treatment. This...

Inflammatory Bowel Disease (IBD) often brings individuals face-to-face with the challenging triad of fatigue, pain, and faecal urgency. In an effort to bring relief,...

The healthcare landscape continually evolves with advances in surgical methodologies, aiming to optimize patient outcomes and enhance cost-efficiency. A recent study sheds light on...

At the American Heart Association's 2025 Scientific Sessions, revolutionary findings emerged about olezarsen's potential in treating severe hypertriglyceridemia (sHTG). These groundbreaking results, presented as...

Recent advancements in the treatment of type 2 diabetes and obesity are drawing attention, particularly with the promising results of tirzepatide. As a dual-action...

Generalized myasthenia gravis presents significant challenges to individuals affected due to its fluctuating muscle weakness. The MycarinG study has emerged as a pivotal investigation...

A recent breakthrough by Camurus has revealed positive data from their Phase 1b study on CAM2056, a monthly semaglutide formulation. Unveiling a significant stride...

In the battle against acute respiratory distress syndrome (ARDS), determining accurate predictors of patient mortality in the ICU is critical. Employing a wide-ranging international...

Regeneron Pharmaceuticals, Inc. and Sanofi have announced impressive outcomes from their recent Phase 3 trial, showcasing the effectiveness of Dupixent in alleviating allergic fungal...

Adherence to inpatient rehab clinical trial protocols significantly influences trial outcomes. However, ensuring strict protocol compliance proves challenging due to the multifaceted nature of...

In a time where diabetes management is increasingly focusing on patient-specific treatment plans, understanding the safety profiles of medications becomes crucial. Recent research scrutinizes...

Takeda Pharmaceutical Company has set a new benchmark in dengue prevention with its QDENGA® dengue vaccine, which has demonstrated an impressive 7-year protective efficacy...

In low-resource settings, the difference in mortality rates between hospitalized children and those in high-resource environments is staggering. At the heart of this issue...

Sumitomo Pharma America, Inc. (SMPA) presents its latest research breakthroughs in the realms of acute myeloid leukemia (AML) and myelofibrosis (MF) at the 67th...